CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
samfilcon A Lenses with EPG01 Packaging Solution +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05126953
NCT05126953N/ACompleted
CompareCT.gov

2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

Bausch & Lomb Incorporated·interventional·Posted Nov 19, 2021·Updated Jul 20, 2025

In Brief

A clinical study evaluating samfilcon A Lenses with EPG01 Packaging Solution and Commercially Available B+L Ultra Lenses for Contact Lens Wearer. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The objective of this 2 hour study is to evaluate the clinical performance of samfilcon A lenses with an alternate packaging solution (EPG01) compared to commercially available B+L Ultra lenses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContact Lens Wearer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 19, 2021
Enrollment StartSep 21, 2021
Primary CompletionSep 23, 2021
TodayJul 2, 2026
Enrollment to primary: 2 daysPosted 4.6 years ago

Interventions

samfilcon A Lenses with EPG01 Packaging Solutiondevice

samfilcon A Lenses with EPG01 Packaging Solution

Commercially Available B+L Ultra Lensesdevice

Commercially Available B+L Ultra Lenses